To be the leading and most trusted partner for global pharmaceutical companies by providing best in class product development and manufacturing solutions.
Pursue scientific excellence in product development, innovation and manufacturing to improve quality of life and create value for our customers, partners and stakeholders worldwide.
VerGo Pharma is an integrated CDMO + CRO providing end-to-end services from product development through clinicals to commercial supply. Our GMP manufacturing site, Formulation R&D and Clinical BA/BE facility are co-located in Goa, India, enabling seamless R&D to commercial frameworks.
Our CMO facility holds multi regulatory GMP approvals (UK-MHRA, SUKL/EU GMP, TGA, WHO, Indian State FDA (Goa FDA)). We specialize in Oral Solids – including Powder for Oral Suspension (PFOS) and Low RH manufacturing – and provide services including Process Optimization Trials, Exhibit Batch Manufacturing, Clinical Batch Supply and Commercial Manufacturing.
Our Formulation R&D team brings extensive expertise across Oral Solids (small and large molecules), Oral Liquids, Powders/Granules/PFOS, FTF/non-infringing strategies and complex/hybrid formulations, enabling innovative solutions tailored to diverse development needs.
Our CRO facility is audited and approved by: CDSCO India, USFDA, UK MHRA, NPRA Malaysia, WHO-Geneva, CMPC Kazakhstan, and offers Clinical BA/BE services including a dedicated In-Vitro Studies Lab. Our expertise spans multiple dosage forms – Oral Solids, Oral Liquids, Oral Thin Films, Suppositories and Injectables – ensuring comprehensive support for varied clinical research needs.
VerGo Pharma is an integrated CDMO + CRO providing end-to-end services from product development through clinicals to commercial supply. Our GMP manufacturing site, Formulation R&D and Clinical BA/BE facility are co-located in Goa, India, enabling seamless R&D to commercial frameworks.
Our CMO facility holds multi regulatory GMP approvals (UK-MHRA, SUKL/EU GMP, TGA, WHO, Indian State FDA (Goa FDA)). We specialize in Oral Solids – including Powder for Oral Suspension (PFOS) and Low RH manufacturing – and provide services including Process Optimization Trials, Exhibit Batch Manufacturing, Clinical Batch Supply and Commercial Manufacturing.
Our Formulation R&D team brings extensive expertise across Oral Solids (small and large molecules), Oral Liquids, Powders/Granules/PFOS, FTF/non-infringing strategies and complex/hybrid formulations, enabling innovative solutions tailored to diverse development needs.
Our CRO facility is audited and approved by: CDSCO India, USFDA, UK MHRA, NPRA Malaysia, WHO-Geneva, CMPC Kazakhstan, and offers Clinical BA/BE services including a dedicated In-Vitro Studies Lab. Our expertise spans multiple dosage forms – Oral Solids, Oral Liquids, Oral Thin Films, Suppositories and Injectables – ensuring comprehensive support for varied clinical research needs.
Expertise Driven Solutions
Thank you to our partners, clients, and prospective collaborators for the engaging discussions and productive meetings at CPHI Milan 2026. We look forward to developing long-term business partnerships and creating value together.
Connect with us: info@vergolabs.com
Bioanalytical Facility successfully closed an unannounced audit with zero observations
This facility represents our continued commitment to innovation, quality research and expanding our capabilities to include in-vitro studies such IVPT, IVRT, NG Tube, Binding and BCS studies.